Literature DB >> 22156202

Defective nuclear IKKα function in patients with ectodermal dysplasia with immune deficiency.

Stephane T Temmerman1, Chi A Ma, Yongge Zhao, Jeffrey Keenan, Ivona Aksentijevich, Margaret Fessler, Margaret R Brown, Alan Knutsen, Ralph Shapiro, Ashish Jain.   

Abstract

Ectodermal dysplasia with immune deficiency (EDI) is an immunological and developmental disorder caused by alterations in the gene encoding NF-κB essential modulator (NEMO; also known as IκB kinase γ subunit [IKKγ]). Missense mutations in the gene encoding NEMO are associated with reduced signal-induced nuclear translocation of NF-κB proteins, resulting in defective expression of NF-κB target genes. Here, we report 2 unrelated male patients with EDI, both of whom have normal NEMO coding sequences, but exhibit a marked reduction in expression of full-length NEMO protein. TLR4 stimulation of APCs from these patients induced normal cytoplasmic activation and nuclear translocation of NF-κB. However, cells deficient in full-length NEMO were defective in expression of NF-κB-regulated cytokines, such as IL-12, suggesting a downstream defect in chromatin accessibility for NF-κB transcription factors. TLR4-stimulated APCs from the patients were defective in IKKα-dependent H3 histone phosphorylation at the IL-12 promoter and recruitment of NF-κB heterodimers RelA and cRel to the promoter. Expression of a super-active form of IKKα restored IL-12 production in a NEMO knockdown human monocytic cell line following LPS treatment. Our findings suggest that NEMO regulates the nuclear function of IKKα and offer new insights into the mechanisms underlying diminished NF-κB signaling in patients with EDI.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22156202      PMCID: PMC3248277          DOI: 10.1172/JCI42534

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  An N-terminal nuclear export signal is required for the nucleocytoplasmic shuttling of IkappaBalpha.

Authors:  C Johnson; D Van Antwerp; T J Hope
Journal:  EMBO J       Date:  1999-12-01       Impact factor: 11.598

2.  Cytoplasmic sequestration of rel proteins by IkappaBalpha requires CRM1-dependent nuclear export.

Authors:  W F Tam; L H Lee; L Davis; R Sen
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

3.  Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway.

Authors:  U Senftleben; Y Cao; G Xiao; F R Greten; G Krähn; G Bonizzi; Y Chen; Y Hu; A Fong; S C Sun; M Karin
Journal:  Science       Date:  2001-08-24       Impact factor: 47.728

4.  X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling.

Authors:  R Döffinger; A Smahi; C Bessia; F Geissmann; J Feinberg; A Durandy; C Bodemer; S Kenwrick; S Dupuis-Girod; S Blanche; P Wood; S H Rabia; D J Headon; P A Overbeek; F Le Deist; S M Holland; K Belani; D S Kumararatne; A Fischer; R Shapiro; M E Conley; E Reimund; H Kalhoff; M Abinun; A Munnich; A Israël; G Courtois; J L Casanova
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

5.  Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia.

Authors:  A Jain; C A Ma; S Liu; M Brown; J Cohen; W Strober
Journal:  Nat Immunol       Date:  2001-03       Impact factor: 25.606

6.  A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO).

Authors:  J Zonana; M E Elder; L C Schneider; S J Orlow; C Moss; M Golabi; S K Shapira; P A Farndon; D W Wara; S A Emmal; B M Ferguson
Journal:  Am J Hum Genet       Date:  2000-10-24       Impact factor: 11.025

7.  Dendritic cells from humans with hypomorphic mutations in IKBKG/NEMO have impaired mitogen-activated protein kinase activity.

Authors:  Chi A Ma; Hong-Ying Wang; Stephane Temmerman; Yongge Zhao; Liming Wu; Ronald L Hornung; Diane Wara; Ashish Jain
Journal:  Hum Mutat       Date:  2011-03       Impact factor: 4.878

8.  Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium.

Authors:  A Smahi; G Courtois; P Vabres; S Yamaoka; S Heuertz; A Munnich; A Israël; N S Heiss; S M Klauck; P Kioschis; S Wiemann; A Poustka; T Esposito; T Bardaro; F Gianfrancesco; A Ciccodicola; M D'Urso; H Woffendin; T Jakins; D Donnai; H Stewart; S J Kenwrick; S Aradhya; T Yamagata; M Levy; R A Lewis; D L Nelson
Journal:  Nature       Date:  2000-05-25       Impact factor: 49.962

9.  Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO.

Authors:  Chee-Kwee Ea; Li Deng; Zong-Ping Xia; Gabriel Pineda; Zhijian J Chen
Journal:  Mol Cell       Date:  2006-04-06       Impact factor: 17.970

10.  Multiple pathogenic and benign genomic rearrangements occur at a 35 kb duplication involving the NEMO and LAGE2 genes.

Authors:  S Aradhya; T Bardaro; P Galgóczy; T Yamagata; T Esposito; H Patlan; A Ciccodicola; A Munnich; S Kenwrick; M Platzer; M D'Urso; D L Nelson
Journal:  Hum Mol Genet       Date:  2001-10-15       Impact factor: 6.150

View more
  7 in total

1.  CYLD and the NEMO Zinc Finger Regulate Tumor Necrosis Factor Signaling and Early Embryogenesis.

Authors:  Yongge Zhao; Chi A Ma; Liming Wu; Kazuhiro Iwai; Jonathan D Ashwell; Eugene M Oltz; Dean W Ballard; Ashish Jain
Journal:  J Biol Chem       Date:  2015-07-29       Impact factor: 5.157

2.  Utility of next generation sequencing in clinical primary immunodeficiencies.

Authors:  Nikita Raje; Sarah Soden; Douglas Swanson; Christina E Ciaccio; Stephen F Kingsmore; Darrell L Dinwiddie
Journal:  Curr Allergy Asthma Rep       Date:  2014-10       Impact factor: 4.919

3.  Autoimmune polyglandular syndrome type 3c with ectodermal dysplasia, immune deficiency and hemolytic-uremic syndrome.

Authors:  Mithat Büyükçelik; Mehmet Keskin; Özlem Keskin; Ali Bay; Beltinge Demircioğlu Kılıç; Yılmaz Kor; M Arda Kılınç; Ayşe Balat
Journal:  J Clin Res Pediatr Endocrinol       Date:  2014

4.  Modulation of TNF-α mRNA stability by human antigen R and miR181s in sepsis-induced immunoparalysis.

Authors:  Cao Dan; Bian Jinjun; Hua Zi-Chun; Ma Lin; Chen Wei; Zhang Xu; Zhou Ri; Cheng Shun; Sun Wen-Zhu; Jiao Qing-Cai; Yin Wu
Journal:  EMBO Mol Med       Date:  2015-02       Impact factor: 12.137

5.  NF-κB Essential Modulator Deficiency Leading to Disseminated Cutaneous Atypical Mycobacteria.

Authors:  Jonathan Braue; Vagishwari Murugesan; Steven Holland; Nishit Patel; Eknath Naik; Jennifer Leiding; Abraham Tareq Yacoub; Carlos N Prieto-Granada; John Norman Greene
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-01-01       Impact factor: 2.576

6.  Hematopoietic stem cell transplantation in 29 patients hemizygous for hypomorphic IKBKG/NEMO mutations.

Authors:  Charline Miot; Kohsuke Imai; Chihaya Imai; Anthony J Mancini; Zeynep Yesim Kucuk; Tokomki Kawai; Ryuta Nishikomori; Etsuro Ito; Isabelle Pellier; Sophie Dupuis Girod; Jeremie Rosain; Shinya Sasaki; Shanmuganathan Chandrakasan; Jana Pachlopnik Schmid; Tsubasa Okano; Estelle Colin; Alberto Olaya-Vargas; Marco Yamazaki-Nakashimada; Waseem Qasim; Sara Espinosa Padilla; Andrea Jones; Alfons Krol; Nyree Cole; Stephen Jolles; Jack Bleesing; Thomas Vraetz; Andrew R Gennery; Mario Abinun; Tayfun Güngör; Beatriz Costa-Carvalho; Antonio Condino-Neto; Paul Veys; Steven M Holland; Gulbu Uzel; Despina Moshous; Benedicte Neven; Stéphane Blanche; Stephan Ehl; Rainer Döffinger; Smita Y Patel; Anne Puel; Jacinta Bustamante; Erwin W Gelfand; Jean-Laurent Casanova; Jordan S Orange; Capucine Picard
Journal:  Blood       Date:  2017-07-05       Impact factor: 22.113

Review 7.  Beyond NF-κB activation: nuclear functions of IκB kinase α.

Authors:  Wei-Chien Huang; Mien-Chie Hung
Journal:  J Biomed Sci       Date:  2013-01-23       Impact factor: 8.410

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.